PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia

被引：0
|
作者：
Dalal, Prarthana [1 ]
Dalal, Jignesh [2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Div Hematol Oncol & Bone Marrow Transplant, Cleveland, OH 44106 USA
来源：
LEUKEMIA & LYMPHOMA | 2024年
关键词：
D O I：
10.1080/10428194.2024.2379976
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-thymocyte globulin to prevent graft versus host disease after HLA matched related allogeneic hematopoietic cell transplantation in acute leukemia patients
    Yafour, N.
    Serradj, F.
    Osmani, S.
    Bouamama, F.
    Brahimi, M.
    Chekkal, M.
    Bouhafs, K.
    Baki, A.
    Arabi, A.
    Bouhass, R.
    Bekadja, M. A.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 216 - 217
  • [42] Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
    Moiseev, Ivan S.
    Pirogova, Olga V.
    Alyanski, Alexandr L.
    Babenko, Elena V.
    Gindina, Tatyana L.
    Darskaya, Elena I.
    Slesarchuk, Olga A.
    Bondarenko, Sergey N.
    Afanasyev, Boris V.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1037 - 1042
  • [43] Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
    Remberger, Mats
    Tjonnfjord, Geir E.
    Abrahamsen, Ingerid W.
    Ali, Maryan
    Myhre, Anders E.
    Gedde-Dahl, Tobias
    Floisand, Yngvar
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (07): : 621.e1 - 621.e3
  • [44] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplants
    Deotare, Uday
    Loach, David
    Michelis, Frank
    Kim, Dennis
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans
    Viswabandya, Auro
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S315 - S315
  • [45] Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Jullien, Maxime
    Orvain, Corentin
    Berceanu, Ana
    Couturier, Marie-Anne
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Klemencie, Marion
    Schmidt, Aline
    Hunault, Mathilde
    Daguindau, Etienne
    Roussel, Xavier
    Delepine, Pascal
    Guillerm, Gaelle
    Giltat, Aurelien
    Francois, Sylvie
    Thepot, Sylvain
    Le Gouill, Steven
    Bene, Marie-C
    Chevallier, Patrice
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 861.e1 - 861.e7
  • [46] Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin
    Qazilbash, Muzaffar
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday
    Hosing, Chitra
    Khouri, Issa
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 444 - 455
  • [47] Allogeneic Hematopoietic Cell Transplantation (AHCT) in Post Infusion Cyclophosphamide (PIC) Era: The Switch from Anti-Thymocyte Globulin (ATG) to PIC for Graft Versus Host Disease (GVHD) Prophylaxis in AHCT from Alternative Donors
    Sahin, Deniz Goren
    Ozcelik, Nurcan
    Ozcelik, Tulay E.
    Arat, Mutlu
    [J]. BLOOD, 2019, 134
  • [48] Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
    Sara Butera
    Marco Cerrano
    Lucia Brunello
    Chiara Maria Dellacasa
    Danilo Giuseppe Faraci
    Sara Vassallo
    Nicola Mordini
    Roberto Sorasio
    Francesco Zallio
    Alessandro Busca
    Benedetto Bruno
    Luisa Giaccone
    [J]. Annals of Hematology, 2021, 100 : 1837 - 1847
  • [49] Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
    Nunes, Natalia S.
    Kanakry, Christopher G.
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [50] Effective Strategy to Prevent Acute Graft-Versus-Host Disease in Unrelated Donor Allogeneic Hematopoietic Cell Transplants By Using a Combination of Anti-Thymocyte Globulin (ATG), Post-Transplant Cyclophosphamide and Cyclosporine
    Deotare, Uday
    Loach, David
    Michelis, Fotios V.
    Kim, Dennis D.
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans A.
    Viswabandya, Auro
    [J]. BLOOD, 2016, 128 (22)
12345